G

Glaukos

Medical devices for glaucoma treatment

Director CMC Drug Substance: Small Molecules and Biologics

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeAliso Viejo, CA, USA$190.8k - $238.5kIn-person

About the Job

Requirements

  • At least 12 years of GMP manufacturing experience with a bachelor's degree, or at least 8 years of GMP manufacturing experience with an advanced degree (master's or PhD).
  • At least 3 years of leadership experience managing technical, manufacturing, and/or supply-chain functions.
  • Experience with small molecules is required.
  • Expertise in active pharmaceutical synthesis and process chemistry for small molecules and oligonucleotides, including scale-up and manufacturing operations.
  • Sound knowledge of upstream and downstream biologics process development, including bioreactors, fermenters, purification, formulation and filling, packaging, and/or distribution, as well as data analysis and regulatory requirements.
  • Ability to manage multiple projects and competing priorities in a fast-paced environment.

Responsibilities

  • Lead strategy and operational implementation for research and development, preclinical and clinical product development, and manufacturing through contract development and manufacturing organizations, including life-cycle management for robust, compliant, and efficient production of small molecules, biologics, and oligonucleotides.
  • Provide technical and operational leadership for active pharmaceutical ingredient development and commercialization, ensuring consistent supply, regulatory compliance, quality performance, cost optimization, and alignment with business objectives.
  • Serve as the primary liaison among research and development, manufacturing, quality, regulatory affairs, supply chain, and external manufacturing partners to advance active pharmaceutical development from development through commercial production.
  • Serve as the subject-matter expert for active pharmaceutical ingredient manufacturing technologies, raw materials, and process optimization.
  • Support contract development and manufacturing organization and internal manufacturing, quality, research and development, supply-chain, and regulatory teams.
  • Lead technology transfer and scale-up from research and development or pilot scale to good manufacturing practice manufacture and commercial-ready manufacturing, using phase-appropriate controls.
  • Lead the biologics team in providing technical support during manufacturing campaigns and troubleshooting equipment, raw materials, suppliers, investigations, process deviations, yield improvement, and manufacturing challenges.
  • Analyze manufacturing data to ensure processes remain in control, use statistical tools to drive continuous improvement, and evaluate emerging technologies and opportunities to improve active pharmaceutical ingredient manufacturing efficiency and robustness.
  • Ensure manufacturing development activities comply with applicable good manufacturing practice regulations, industry standards, and Occupational Safety and Health Administration requirements.
  • Work with contract development and manufacturing organizations and partners to support audits, inspections, regulatory submissions, and inspection readiness.
  • Collaborate with regulatory teams to provide technical support for filings, review chemistry, manufacturing, and controls documentation related to active pharmaceutical development and production, and support responses to regulatory inquiries.
  • Support contract development and manufacturing organization selection and audits, perform strategic planning, and lead cross-functional initiatives.

Desired Qualifications

  • An advanced degree (master's or PhD) in chemistry, chemical engineering, biochemistry, pharmaceutical sciences, or a related field is preferred.
  • Experience with contract development and manufacturing organizations is preferred.
  • Experience with microbial, mammalian, and/or oligonucleotide processes is preferred.

About the Company

Glaukos

Medical devices for glaucoma treatment

Glaukos focuses on ophthalmology by developing and commercializing medical devices and therapies for glaucoma, corneal disorders, and retinal diseases. Its products mainly target surgeons who treat eye conditions, with a core technology in micro invasive glaucoma surgery (MIGS). The company’s MIGS devices, such as the Trabecular Micro Bypass Stent and next-generation iStent, are implanted in the eye to improve outflow of eye fluid and lower intraocular pressure, offering a less invasive option compared with traditional surgeries. Glaukos differentiates itself by pioneering MIGS and bringing the first US-approved MIGS device to market in 2012, continuing to expand its portfolio through research, development, and strategic acquisitions. The company aims to improve patient care by providing safer, effective, and longer-lasting treatment options for glaucoma and related eye diseases, addressing unmet needs in ophthalmology.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Aliso Viejo, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Glaukos

See more jobs